Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI Insights From the PROSPECT II TrialCardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA..
Univ Copenhagen, Copenhagen, Denmark..
Zealand Univ Hosp, Dept Cardiol, Roskilde, Denmark..
Aarhus Univ, Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark..
Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA..
Univ Calif San Diego, Div Cardiol, San Diego, CA USA..
Aarhus Univ, Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark..
Karolinska Inst, Danderyd Univ Hosp, Stockholm, Sweden..
St Olavs Univ Hosp, Clin Cardiol, Trondheim, Norway..
Odense Univ Hosp, Dept Cardiol, Odense, Denmark..
Univ Bergen, Dept Clin Sci, Bergen, Norway..
St Olavs Univ Hosp, Clin Cardiol, Trondheim, Norway..
Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Solna, Sweden..
Haukeland Hosp, Dept Heart Dis, Bergen, Norway..
Columbia Univ, New York Presbyterian Hosp, Irving Med Ctr, New York, NY USA.;Columbia Univ, Irving Med Ctr, Div Cardiol, New York, NY USA..
Sahlgrens Univ Hosp, Dept Mol & Clin Med Cardiol, Gothenburg, Sweden..
Lund Univ, Dept Cardiol Clin Sci, Lund, Sweden..
Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA..
Show others and affiliations
2025 (English)In: JACC: Cardiovascular Interventions, ISSN 1936-8798, E-ISSN 1876-7605, Vol. 18, no 10, p. 1217-1228Article in journal (Refereed) Published
Abstract [en]
BACKGROUND Inflammation is a driver of atherosclerosis and susceptibility to cardiovascular events.
OBJECTIVES The authors sought to evaluate whether high-sensitivity C-reactive protein (hsCRP) levels are associated with the prevalence of high-risk coronary plaques in patients with non-ST-segment elevation myocardial infarction (NSTEMI).
METHODS PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II was a multicenter, prospective study enrolling patients with recent myocardial infarction. Following treatment of all flow-limiting lesions, 3-vessel imaging with near-infrared spectroscopy and intravascular ultrasound was used to characterize untreated nonculprit lesions. We investigated the association between baseline hsCRP and plaque morphology (lipid content, plaque burden, lumen area) in 501 NSTEMI patients. hsCRP levels were categorized as low (<1 mg/L), intermediate (1-3 mg/L), or high (>3 mg/L).
RESULTS The percentages of patients with at least 1 highly lipidic plaque (maximum lipid core burden index for any 4-mm pullback length >= 324.7) increased from 39.4% to 57.2% to 59.3% in the low, intermediate, and high hsCRP groups, respectively (P = 0.01). The proportion of patients with at least 1 highly lipidic plaque with >= 70% burden increased with hsCRP levels from 22.7% to 27.2% to 36.7%, respectively (P = 0.01). Multivariable analyses showed that increasing hsCRP was associated with higher total coronary artery lipid core burden index and plaque volume. Higher hsCRP increased the odds of having any highly lipidic plaque and those with >= 70% plaque burden.
CONCLUSIONS Among patients with recent NSTEMI, a high baseline hsCRP level was associated with the presence of pan-coronary atherosclerosis and focal high-risk plaques. (PROSPECT II & PROSPECT ABSORB-an Integrated Natural History Study and Randomized Trial; NCT02171065) (JACC Cardiovasc Interv. 2025;18:1217-1228) (c) 2025 by the American College of Cardiology Foundation.
Place, publisher, year, edition, pages
Elsevier, 2025. Vol. 18, no 10, p. 1217-1228
Keywords [en]
atherosclerosis, cardiovascular event(s), coronary plaques, inflammation, intravascular ultrasound, myocardial infarction, near-infrared spectroscopy, non-ST-segment elevation myocardial infarction
National Category
Cardiology and Cardiovascular Disease
Identifiers
URN: urn:nbn:se:uu:diva-559543DOI: 10.1016/j.jcin.2025.01.440ISI: 001503416800002PubMedID: 40272345Scopus ID: 2-s2.0-105004884566OAI: oai:DiVA.org:uu-559543DiVA, id: diva2:1970282
2025-06-162025-06-162025-06-16Bibliographically approved